| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Conversion from cyclosporine to tacrolimus in renal transplant recipients with gum hyperplasia
|
Kohnle, M
|
|
1999
|
31 |
7S1 |
p. 44-45
2 p.
|
artikel
|
| 2 |
Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation
|
Kliem, V
|
|
1999
|
31 |
7S1 |
p. 37-40
4 p.
|
artikel
|
| 3 |
Conversion to tacrolimus in hyperlipidemic patients
|
Friemann, S
|
|
1999
|
31 |
7S1 |
p. 41-43
3 p.
|
artikel
|
| 4 |
Corticosteroid withdrawal under tacrolimus primary and rescue therapy in renal transplantation: the Chicago experience
|
Woodle, E.S
|
|
1999
|
31 |
7S1 |
p. 84-85
2 p.
|
artikel
|
| 5 |
Dosing and management guidelines for tacrolimus in renal transplant patients
|
van Hooff, J.P
|
|
1999
|
31 |
7S1 |
p. 54-57
4 p.
|
artikel
|
| 6 |
Editorial
|
|
|
1999
|
31 |
7S1 |
p. 1-
1 p.
|
artikel
|
| 7 |
Effect of immunosuppressive therapy on graft half-life projections
|
Opelz, G
|
|
1999
|
31 |
7S1 |
p. 31-33
3 p.
|
artikel
|
| 8 |
Four-year follow-up of the European Tacrolimus Multicenter Renal Study
|
Mayer, A.D
|
|
1999
|
31 |
7S1 |
p. 27-28
2 p.
|
artikel
|
| 9 |
Immunological and nonimmunological risk factors with tacrolimus and Neoral in renal transplant recipients: an interim report
|
Jurewicz, W.A
|
|
1999
|
31 |
7S1 |
p. 64-66
3 p.
|
artikel
|
| 10 |
Mechanisms of chronic rejection
|
Häyry, P
|
|
1999
|
31 |
7S1 |
p. 5-8
4 p.
|
artikel
|
| 11 |
Outcome of tacrolimus conversion therapy for renal allograft rejection: 5-year follow-up
|
Jordan, M.L
|
|
1999
|
31 |
7S1 |
p. 81-83
3 p.
|
artikel
|
| 12 |
Pharmacokinetics of tacrolimus: clinically relevant aspects
|
Undre, N.A
|
|
1999
|
31 |
7S1 |
p. 21-24
4 p.
|
artikel
|
| 13 |
Report of the first 118 tacrolimus-treated patients at St George’s Hospital, London
|
Oliveira, D.B.G
|
|
1999
|
31 |
7S1 |
p. 61-63
3 p.
|
artikel
|
| 14 |
Single-center experience with initial intravenous dosing of tacrolimus after kidney transplantation
|
Soriano, S
|
|
1999
|
31 |
7S1 |
p. 51-53
3 p.
|
artikel
|
| 15 |
Tacrolimus and glucose metabolism
|
van Hooff, J.P
|
|
1999
|
31 |
7S1 |
p. 49-50
2 p.
|
artikel
|
| 16 |
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients
|
Forsythe, J
|
|
1999
|
31 |
7S1 |
p. 69-71
3 p.
|
artikel
|
| 17 |
Tacrolimus-based immunosuppression in pediatric renal transplantation
|
Jordan, M.L
|
|
1999
|
31 |
7S1 |
p. 29-30
2 p.
|
artikel
|
| 18 |
Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 De Octubre, Madrid
|
Morales, J.M
|
|
1999
|
31 |
7S1 |
p. 75-77
3 p.
|
artikel
|
| 19 |
The Benelux experience with the combination of tacrolimus and mycophenolate mofetil
|
Squifflet, J.P
|
|
1999
|
31 |
7S1 |
p. 72-74
3 p.
|
artikel
|
| 20 |
The effects of lipids on graft outcome
|
Fellström, B
|
|
1999
|
31 |
7S1 |
p. 14-15
2 p.
|
artikel
|
| 21 |
The future of new immunosuppressive drugs
|
Paul, L.C
|
|
1999
|
31 |
7S1 |
p. 16-18
3 p.
|
artikel
|
| 22 |
The role of transforming growth factor-β in transplant rejection
|
Hutchinson, I.V
|
|
1999
|
31 |
7S1 |
p. 9-13
5 p.
|
artikel
|
| 23 |
Vascular rejection with tacrolimus and potential long-term graft outcome
|
Vanrenterghem, Y
|
|
1999
|
31 |
7S1 |
p. 86-87
2 p.
|
artikel
|
Tijdschrift beschrijving